1. Home
  2. SVT vs MRKR Comparison

SVT vs MRKR Comparison

Compare SVT & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVT
  • MRKR
  • Stock Information
  • Founded
  • SVT 1959
  • MRKR N/A
  • Country
  • SVT United States
  • MRKR United States
  • Employees
  • SVT N/A
  • MRKR N/A
  • Industry
  • SVT Industrial Machinery/Components
  • MRKR Biotechnology: Pharmaceutical Preparations
  • Sector
  • SVT Consumer Discretionary
  • MRKR Health Care
  • Exchange
  • SVT Nasdaq
  • MRKR Nasdaq
  • Market Cap
  • SVT 28.3M
  • MRKR 30.7M
  • IPO Year
  • SVT N/A
  • MRKR N/A
  • Fundamental
  • Price
  • SVT $10.31
  • MRKR $3.80
  • Analyst Decision
  • SVT
  • MRKR Strong Buy
  • Analyst Count
  • SVT 0
  • MRKR 1
  • Target Price
  • SVT N/A
  • MRKR $19.00
  • AVG Volume (30 Days)
  • SVT 957.0
  • MRKR 91.1K
  • Earning Date
  • SVT 11-08-2024
  • MRKR 11-14-2024
  • Dividend Yield
  • SVT N/A
  • MRKR N/A
  • EPS Growth
  • SVT N/A
  • MRKR N/A
  • EPS
  • SVT 0.05
  • MRKR N/A
  • Revenue
  • SVT $47,487,000.00
  • MRKR $5,395,849.00
  • Revenue This Year
  • SVT N/A
  • MRKR $35.94
  • Revenue Next Year
  • SVT N/A
  • MRKR N/A
  • P/E Ratio
  • SVT $229.14
  • MRKR N/A
  • Revenue Growth
  • SVT 19.50
  • MRKR 79.04
  • 52 Week Low
  • SVT $10.25
  • MRKR $2.44
  • 52 Week High
  • SVT $14.10
  • MRKR $6.16
  • Technical
  • Relative Strength Index (RSI)
  • SVT 30.43
  • MRKR 50.16
  • Support Level
  • SVT $10.25
  • MRKR $3.47
  • Resistance Level
  • SVT $10.80
  • MRKR $5.95
  • Average True Range (ATR)
  • SVT 0.10
  • MRKR 0.63
  • MACD
  • SVT -0.03
  • MRKR 0.01
  • Stochastic Oscillator
  • SVT 6.12
  • MRKR 16.99

About SVT Servotronics Inc.

Servotronics Inc is a U.S based company that designs, manufactures, and markets servo valves, including torque motor, hydraulic, and pneumatic valves. The company has single reportable segment which is aerospace Its products are marketed and sold throughout the United States and in select foreign markets. These products are sold to commercial aviation manufacturers, government prime contractors, government subcontractors, and end-users.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.

Share on Social Networks: